Vermilion Jennifer, Johnson Mahlon, Srinivasan Jayasri, Mink Jonathan W
University of Rochester, Rochester, NY, USA.
Royal Children's Hospital, Parkville, Victoria, Australia.
J Child Neurol. 2019 Nov;34(13):801-805. doi: 10.1177/0883073819860566. Epub 2019 Jul 15.
Neuronal intranuclear inclusion disease is a rare, neurodegenerative disorder with onset in childhood. We report a single case natural history over 10 years and present a review of juvenile parkinsonism and neuronal intranuclear inclusion disease. Our patient was initially seen at the University of Rochester at age 12 years after 4 years of progressive dysarthria, dysphagia, and clumsiness. His neurologic examination was notable for parkinsonism. He had excellent initial response to levodopa, but subsequently developed dopa-induced motor fluctuations, dyskinesias, psychosis, and dystonia. Later in the course, he developed multiple nonmotor symptoms and ultimately died from respiratory failure. Neuropathology demonstrated large eosinophilic nuclear inclusions and small ubiquitin-related modifier 1 (SUMO-1) immunoreactivity, confirming the diagnosis of neuronal intranuclear inclusion disease. This diagnosis should be considered in a patient presenting with juvenile parkinsonism. Clues to the diagnosis include early-onset dopa-induced dyskinesias, gastrointestinal dysfunction, and oculogyric crises.
神经元核内包涵体病是一种罕见的儿童期起病的神经退行性疾病。我们报告了一例10年的自然病程,并对青少年帕金森病和神经元核内包涵体病进行了综述。我们的患者最初在罗切斯特大学就诊时为12岁,此前已有4年进行性构音障碍、吞咽困难和笨拙。他的神经系统检查以帕金森病为显著特征。他对左旋多巴最初反应良好,但随后出现了多巴诱导的运动波动、异动症、精神病和肌张力障碍。病程后期,他出现了多种非运动症状,最终死于呼吸衰竭。神经病理学显示有大的嗜酸性核内包涵体和小的泛素相关修饰因子1(SUMO-1)免疫反应性,证实了神经元核内包涵体病的诊断。对于出现青少年帕金森病的患者应考虑这一诊断。诊断线索包括早发性多巴诱导的异动症、胃肠功能障碍和动眼危象。